The document discusses percutaneous balloon mitral valvuloplasty (PBMV) as a treatment for mitral stenosis (MS), emphasizing the high prevalence of rheumatic heart disease (RHD) in India and its complications, including significant morbidity and mortality. It highlights the epidemiological aspects of rheumatic fever, clinical diagnosis, and the natural history of MS, revealing poor outcomes if significant symptoms develop. The guidelines for indications, contraindications, success factors, and techniques for PBMV are thoroughly outlined to aid in patient management.